The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106350026 10635002 6 F 20140817 20160804 20141205 20160812 EXP CZ-SA-2014SA113201 AVENTIS 30.00 YR A M Y 0.00000 20160812 MD CZ CZ

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106350026 10635002 1 PS LEMTRADA ALEMTUZUMAB 1 Unknown F3005H15 103948 CONCENTRATE FOR SOLUTION FOR INFUSION
106350026 10635002 2 SS LEMTRADA ALEMTUZUMAB 1 Unknown UNKNOWN 103948 CONCENTRATE FOR SOLUTION FOR INFUSION
106350026 10635002 3 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Oral U UNKNOWN 0
106350026 10635002 4 C NOVALGIN METAMIZOLE SODIUM 1 Intravenous (not otherwise specified) 0
106350026 10635002 5 C DEGAN METOCLOPRAMIDE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0
106350026 10635002 6 C PARACETAMOL ACETAMINOPHEN 1 Intravenous (not otherwise specified) 0
106350026 10635002 7 C NEODOLPASSE 2 Intravenous (not otherwise specified) 0
106350026 10635002 8 C NADROPARIN NADROPARIN 1 Subcutaneous 0 .4 ML INJECTION Q12H
106350026 10635002 9 C PHYTOMENADIONE PHYTONADIONE 1 Oral VIGANTOL GTT 0
106350026 10635002 10 C ACIDUM FOLICUM FOLIC ACID 1 Oral 0 TABLET
106350026 10635002 11 C AKTIFERRIN FERROUS SULFATESERINE 1 0 TABLET
106350026 10635002 12 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 20 MG TABLET
106350026 10635002 13 C ITOPRIDE ITOPRIDE 1 Oral 0 50 MG TABLET
106350026 10635002 14 C KALNORMIN POTASSIUM CHLORIDE 1 0 TABLET
106350026 10635002 15 C DIAZEPAM. DIAZEPAM 1 Oral 0 5 MG TABLET QD
106350026 10635002 16 C FLECTOR DICLOFENAC EPOLAMINE 1 LOCAL THERAPY ON KNEES, ANKLES, SHOULDERS 0 GEL

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106350026 10635002 1 Multiple sclerosis
106350026 10635002 2 Multiple sclerosis
106350026 10635002 16 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
106350026 10635002 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
106350026 10635002 CSF cell count increased
106350026 10635002 Chest pain
106350026 10635002 Dermatitis allergic
106350026 10635002 Dyspnoea
106350026 10635002 Fatigue
106350026 10635002 Headache
106350026 10635002 Listeria sepsis
106350026 10635002 Meningitis
106350026 10635002 Oral candidiasis
106350026 10635002 Oral fungal infection
106350026 10635002 Pneumonia
106350026 10635002 Pneumonia fungal
106350026 10635002 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106350026 10635002 1 20140811 20140815 0
106350026 10635002 2 201508 201508 0
106350026 10635002 4 2014 0
106350026 10635002 5 2014 0
106350026 10635002 6 2014 0
106350026 10635002 7 2014 0
106350026 10635002 8 2014 0
106350026 10635002 9 2014 0
106350026 10635002 10 2014 0
106350026 10635002 11 2014 0
106350026 10635002 12 2014 0
106350026 10635002 13 2014 0
106350026 10635002 14 2014 0
106350026 10635002 15 2014 0
106350026 10635002 16 2014 0